Corporate News 10-Sep-18
Ajanta Pharma update on scheme of amalgamation and arrangement
Ajanta Pharma announced that the Hon'ble National Company Law Tribunal, Mumbai Bench ('NCLT') did not deem it fit to approve and sanction the proposed Scheme of Amalgamation and Arrangement between Gabs Investments and Ajanta Pharma and their respective shareholders.
Previous News
Ajanta Pharma spurts as Q4 PAT climbs 66% YoY, board OKs Rs 285-cr share buyback
( Hot Pursuit - 03-May-24 10:22 )
Ajanta Pharma to hold board meeting
( Corporate News - 19-Oct-23 17:17 )
Ajanta Pharma fixes record date for interim dividend
( Market Beat - Reports 03-Nov-22 16:03 )
Ajanta Pharma gains as board to mull share buyback
( Hot Pursuit - 08-Mar-23 09:29 )
Ajanta Pharma to convene board meeting
( Corporate News - 11-May-20 13:28 )
Board of Ajanta Pharma recommends interim dividend
( Corporate News - 01-Nov-18 13:51 )
Ajanta Pharma to conduct AGM
( Corporate News - 01-Jun-23 13:01 )
Ajanta Pharma receives final approval for Entacapone Tablets
( Corporate News - 04-Sep-17 09:19 )
Ajanta Pharma to hold board meeting
( Corporate News - 14-Oct-16 17:14 )
Ajanta Pharma to convene AGM
( Corporate News - 18-Jun-20 13:17 )
Ajanta Pharma standalone net profit declines 10.95% in the September 2017 quarter
( Results - Announcements 31-Oct-17 16:18 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
